Avior Wealth Management
TARO icon

Avior Wealth Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Avior Wealth Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$42 – 3891
2024
Q1 		$42 Buy
+1
New +$42 ﹤0.01% 3520

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Avior Wealth Management's TARO Position: Q2 2024 in Review

Avior Wealth Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 1 share — an estimated $42 sold.

Avior Wealth Management first reported a position in TARO in Q1 2024 and held it in 1 quarter. The position peaked at $42 in Q1 2024. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Avior Wealth Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 1 Taro Pharmaceutical Industries Ltd. share in Q2 2024, an estimated $42.
  • Avior Wealth Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's Taro Pharmaceutical Industries Ltd. position peaked at $42 in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.